Clinical trial
A Phase II Trial of Irinotecan in Recurrent Glioma
NCT00003134 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Irinotecan in Recurrent Glioma
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 1998
- Completion date
- January 31, 2009
- Enrollment
- 64 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
brain and central nervous system tumors